Cited by 208Genetics and Neurodevelopmental DisordersNeuroscience and Neuropharmacology ResearchRNA Research and Splicing

The FXG: a presynaptic fragile X granule expressed in a subset of developing brain circuits

Open access
Christie, Sean B., Akins, Michael R., Schwob, James E., Fallon, Justin R.·2009·The Journal of Neuroscience

Abstract

The loss of Fragile X mental retardation protein (FMRP) causes Fragile X syndrome, the most common inherited mental retardation and single gene cause of autism. Although postsynaptic functions for FMRP are well established, potential roles at the presynaptic apparatus remain largely unexplored. Here, we characterize the expression of FMRP and its homologs, FXR1P and FXR2P, in the developing, mature and regenerating rodent nervous system, with a focus on presynaptic expression. As expected, FMRP is expressed in the somatodendritic domain in virtually all neurons. However, FMRP is also localized in discrete granules (Fragile X granules; FXGs) in a subset of brain regions including frontal cortex, hippocampal area CA3 and olfactory bulb glomeruli. Immunoelectron microscopy shows that FMRP is localized at presynaptic terminals and in axons within these FXG-rich regions. With the exception of the olfactory bulb, FXGs are prominent only in the developing brain. Experiments in regenerating olfactory circuits indicate that peak FXG expression occurs 2–4 weeks after neurogenesis, a period that correlates with synapse formation and refinement. Virtually all FXGs contain FXR2P, while region-selective subsets harbor FMRP and/or FXR1P. Genetic studies show that FXR2P is essential for FXG expression, while FMRP regulates FXG number and developmental profile. These findings suggest that Fragile X proteins play a distinct, presynaptic role during discrete developmental epochs in defined circuits of the mammalian CNS. We propose that the neurological defects in Fragile X syndrome, including the autistic features, could be due in part to the loss of FMRP function in presynaptic compartments.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.3937-08.2009

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Christie, S. B., Akins, M. R., Schwob, J. E., & Fallon, J. R.
Affiliations
  • Brown University (US)
  • Tufts University (US)
Corresponding author
Fallon, Justin R.
Venue
The Journal of Neuroscience
Published
2009-02-04
Volume
29
Issue
5
Pages
1514-1524
ISSN
  • 0270-6474 (ISSN-L)
  • 1529-2401
OpenAlex
W2013080889
Cited by
208
References
53
Citations by year
2026: 4 · 2025: 1 · 2024: 8 · 2023: 11 · 2022: 7 · 2021: 14 · 2020: 18 · 2019: 11 · 2018: 12 · 2017: 12 · 2016: 16 · 2015: 13 · 2014: 13 · 2013: 21 · 2012: 11
FWCI
8.91
Type
journal article
Language
en
Open access
Locations
  • Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute on Aging (AG 02049, T32AG020498)
  • National Institute on Drug Abuse (F32DA021501, DA021501)
  • National Institute on Deafness and Other Communication Disorders (R01DC002167, DC002167)
  • National Institute of Neurological Disorders and Stroke (P01NS039321)
  • National Center for Research Resources (P20RR015578)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD052083, HD052083)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
Keywords
fragile X syndrome, FMRP, FXR1P, presynaptic localization, synaptogenesis, synapse refinement, olfactory bulb, hippocampal CA3, frontal cortex, axons, nervous system regeneration, neurogenesis, autism spectrum disorder, intellectual disability, brain development
MeSH terms
Animals, Brain, Frontal Lobe, Hippocampus, Humans, Male, Mice, Inbred C57BL, Nerve Net, Olfactory Bulb, Rats, Sprague-Dawley, Presynaptic Terminals, Mice, Knockout, Gene Expression Regulation, Developmental, Mice, Rats, Fragile X Messenger Ribonucleoprotein 1, Neurogenesis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review